Effect of garlic on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled clinical trials

被引:46
作者
Sahebkar, Amirhossein [1 ,2 ]
Serban, Corina [3 ]
Ursoniu, Sorin [3 ]
Banach, Maciej [4 ]
机构
[1] Mashhad Univ Med Sci, Biotechnol Res Ctr, Mashhad, Iran
[2] Univ Western Australia, Sch Med & Pharmacol, Royal Perth Hosp, Metab Res Ctr, Perth, WA 6009, Australia
[3] Victor Babes Univ Med & Pharm, Discipline Pathophysiol, Dept Funct Sci, Timisoara, Romania
[4] Med Univ Lodz, Chair Nephrol & Hypertens, Dept Hypertens, Lodz, Poland
关键词
Lipoprotein(a); Garlic; Allium sativum; Lipids; ALLIUM-SATIVUM L; SERUM-CHOLESTEROL; BLOOD-PRESSURE; LIPIDS; POWDER; OXIDATION; THERAPY; ACID;
D O I
10.1016/j.nut.2015.06.009
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objectives: Garlic can play an essential role in the prevention of atherosclerosis, but the research addressing the effect of garlic on the concentration of lipoprotein(a) [Lp(a)] has not been fully demonstrated. The aim of this study was to assess the effect of garlic on plasma Lp(a) concentrations through systematic review of literature and meta-analysis of available randomized controlled trials. Methods: The literature search included SCOPUS, PubMed-Medline, ISI Web of Science, and Google Scholar databases up to March 10, 2015 to identify randomized controlled trials investigating the effect of garlic on plasma Lp(a) concentrations. Two independent reviewers extracted data on study characteristics, methods, and outcomes. Overall, the effect of garlic on plasma Lp(a) levels was reported in six trials. Results: Meta-analysis did not suggest a significant alteration in plasma Lp(a) levels after garlic consumption (weighted mean difference [WMD] = 16.86%; 95% confidence interval, -4.59 to 38.31; P = 0.124). This result was robust in the leave-one-out sensitivity analysis. When the studies were categorized according to the duration of supplementation, there was no effect in the subgroup of trials lasting <12 wk (WMD = 2.01%; 95% CI, -14.67 to 18.68; P = 0.813) but a significant elevation of plasma Lp(a) concentrations was found in trials lasting >12 wk (WMD = 54.59%; 95% CI, 30.47-78.71; P < 0.001). Random-effects meta-regression suggested an inverse association between the changes in plasma concentrations of Lp(a) and duration of supplementation (slope 1.71; 95% CI, 0.46-2.97; P = 0.007). Conclusions: The present meta-analysis did not suggest a significant effect of garlic supplementation on the reduction of Lp(a) levels. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:33 / 40
页数:8
相关论文
共 50 条
  • [21] Impact of alirocumab/evolocumab on lipoprotein (a) concentrations in patients with familial hypercholesterolaemia: a systematic review and meta-analysis of randomized controlled trials
    Dai, Haibing
    Zhu, Yonglin
    Chen, Zuyi
    Yan, Renqing
    Liu, Jinsong
    He, Ziyun
    Zhang, Lin
    Zhang, Feng
    Yan, Shengkai
    ENDOKRYNOLOGIA POLSKA, 2023, 74 (03) : 234 - 242
  • [22] Effect of Pilates on Glucose and Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Chen, Zehua
    Ye, Xiangling
    Xia, Yubo
    Song, Huiting
    Wang, Yi
    Guan, Yingxin
    Shen, Zhen
    Chen, Weijian
    Jiang, Tao
    Wu, Huai
    Xu, Xuemeng
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [23] Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials
    Fogacci, Federica
    Tocci, Giuliano
    Presta, Vivianne
    Fratter, Andrea
    Borghi, Claudio
    Cicero, Arrigo F. G.
    CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2019, 59 (10) : 1605 - 1618
  • [24] The effect of chromium supplementation on apolipoproteins: A systematic review and meta-analysis of randomized clinical trials
    Shahinfar, Hossein
    Amini, Mohammad Reza
    Sheikhhossein, Fatemeh
    Djafari, Farhang
    Jafari, Alireza
    Shab-Bidar, Sakineh
    CLINICAL NUTRITION ESPEN, 2020, 40 : 34 - 41
  • [25] Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Serban, Maria-Corina
    Sahebkar, Amirhossein
    Zanchetti, Alberto
    Mikhailidis, Dimitri P.
    Howard, George
    Antal, Diana
    Andrica, Florina
    Ahmed, Ali
    Aronow, Wilbert S.
    Muntner, Paul
    Lip, Gregory Y. H.
    Graham, Ian
    Wong, Nathan
    Rysz, Jacek
    Banach, Maciej
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (07):
  • [26] The effects of garlic supplementation on oxidative stress markers: A systematic review and meta-analysis of randomized controlled trials
    Moosavian, Seyedeh Parisa
    Arab, Arman
    Paknahad, Zamzam
    Moradi, Sajjad
    COMPLEMENTARY THERAPIES IN MEDICINE, 2020, 50
  • [27] The effect of garlic intake on glycemic control in humans: a systematic review and meta-analysis
    Emami, Shaghayegh
    Rouhani, Mohammad Hossein
    Azadbakht, Leila
    PROGRESS IN NUTRITION, 2017, 19 : 10 - 18
  • [28] Effects of aged garlic extract on blood pressure in hypertensive patients: A systematic review and meta-analysis of randomized controlled trials
    Saadh, Mohamed J.
    Kariem, Muthena
    Shukla, Madhu
    Ballal, Suhas
    Kumar, Abhishek
    Chahar, Mamata
    Saini, Suman
    Kapila, Ish
    Hasaanzadeh, Shirin
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2024, 175
  • [29] Effects of garlic supplementation on oxidative stress and antioxidative capacity biomarkers: A systematic review and meta-analysis of randomized controlled trials
    Askari, Mohammadreza
    Mozaffari, Hadis
    Darooghegi Mofrad, Manije
    Jafari, Alireza
    Surkan, Pamela J.
    Amini, Mohammad Reza
    Azadbakht, Leila
    PHYTOTHERAPY RESEARCH, 2021, 35 (06) : 3032 - 3045
  • [30] Effect of Sibutramine on Plasma C-Reactive Protein, Leptin and Adiponectin Concentrations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    De Vincentis, Antonio
    Pedone, Claudio
    Vespasiani-Gentilucci, Umberto
    Picardi, Antonio
    Derosa, Giuseppe
    Maffioli, Pamela
    Sahebkar, Amirhossein
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (06) : 870 - 878